Skip to Content

USPSTF Finds Evidence Lacking for Child HTN Screening

TUESDAY, Nov. 10, 2020 -- The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is inadequate for assessing the balance of benefits and harms of screening children and adolescents for high blood pressure. These findings form the basis of a final recommendation statement published in the Nov. 10 issue of the Journal of the American Medical Association.

Gerald Gartlehner, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues updated the evidence on screening and treatment of hypertension in children and adolescents (ages 3 to 18 years) for the USPSTF. Data were included from 42 studies from 43 publications, with more than 12,400 participants. The researchers found that none of the studies examined the benefits or harms of screening or the impact of treating childhood hypertension on outcomes in adulthood. One study reported sensitivity and specificity of 0.82 and 0.70, respectively, for two office-based blood pressure measurements. In 20 studies, there was a significant association suggested between childhood hypertension and abnormal blood pressure in adulthood.

Based on these findings, the USPSTF concluded that there is currently insufficient evidence to support screening children and adolescents for high blood pressure; the balance of benefits and harms of screening cannot be ascertained (I statement).

"Although high blood pressure is a serious health issue, there is not enough evidence on whether or not screening children and teens leads to better long-term health," task force member Michael Silverstein, M.D., M.P.H., said in a statement. "Clinicians should use their best judgement about whether or not to screen youth who do not have signs or symptoms."

Evidence Report

Recommendation Statement

Editorial 1

Editorial 2

© 2021 HealthDay. All rights reserved.

Posted: November 2020

Read this next

Continuing Blood Pressure Meds Safe for Those With COVID-19

WEDNESDAY, Jan. 20, 2021 -- Hospitalized COVID-19 patients can safely continue using blood pressure medications, according to a study published online Jan. 7 in The Lancet...

Ischemic Heart, Hypertensive Disease Deaths Up During COVID-19

TUESDAY, Jan. 12, 2021 -- During the initial phase of the COVID-19 pandemic, there was an increase in deaths caused by ischemic heart disease and hypertensive diseases in the...

Review Confirms Interarm SBP Difference, Mortality Link

FRIDAY, Jan. 8, 2021 -- The associations between interarm differences in systolic blood pressure and all-cause mortality, cardiovascular mortality, and cardiovascular disease have...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.